Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Risk of leukemia after chemotherapy and radiation treatment for breast cancer.

Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN.

N Engl J Med. 1992 Jun 25;326(26):1745-51.

3.

Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.

Kröger N, Damon L, Zander AR, Wandt H, Derigs G, Ferrante P, Demirer T, Rosti G; Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation; German Adjuvant Breast Cancer Study Group; University of California, San Francisco.

Bone Marrow Transplant. 2003 Dec;32(12):1153-7. Review.

PMID:
14647269
4.

Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment.

van Leeuwen FE.

Baillieres Clin Haematol. 1996 Mar;9(1):57-85. Review.

PMID:
8730551
6.

Secondary myelodysplastic syndromes and leukaemias.

Levine EG, Bloomfield CD.

Clin Haematol. 1986 Nov;15(4):1037-80. Review.

PMID:
3552347
7.

Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.

Levine EG, Bloomfield CD.

Semin Oncol. 1992 Feb;19(1):47-84. Review.

PMID:
1736370
8.

Second cancers following antineoplastic therapy.

Dorr FA, Coltman CA Jr.

Curr Probl Cancer. 1985 Feb;9(2):1-43. Review.

PMID:
3888536
9.

Carcinogenic effects of radiotherapy for breast cancer.

Neugut AI, Weinberg MD, Ahsan H, Rescigno J.

Oncology (Williston Park). 1999 Sep;13(9):1245-56; discussion 1257, 1261-5. Review.

PMID:
10509322
10.

Late effects of adjuvant therapy for breast cancer.

Shapiro CL, Recht A.

J Natl Cancer Inst Monogr. 1994;(16):101-12. Review. No abstract available.

PMID:
7999452
11.

Second cancers after breast cancer treatment.

Matesich SM, Shapiro CL.

Semin Oncol. 2003 Dec;30(6):740-8. Review.

PMID:
14663775
12.

Acute myelogenous leukemia and myelodysplasia secondary to breast cancer treatment: case studies and literature review.

Cole M, Strair R.

Am J Med Sci. 2010 Jan;339(1):36-40. doi: 10.1097/MAJ.0b013e3181bedb74. Review.

PMID:
19996729
13.

Late effect of atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes.

Tsushima H, Iwanaga M, Miyazaki Y.

Int J Hematol. 2012 Mar;95(3):232-8. doi: 10.1007/s12185-012-1002-4. Epub 2012 Feb 28. Review.

PMID:
22370711
14.

Therapy related myelodysplastic syndrome: a case report and review of literature.

Sonawane S, Gadgil N, Margam S.

Indian J Pathol Microbiol. 2011 Apr-Jun;54(2):371-3. doi: 10.4103/0377-4929.81643. Review.

15.

Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer.

Falkson G, Gelman RS, Dreicer R, Tormey DC, Alberts AS, Coccia-Portugal MA, Rushing D, Bennett JM.

J Clin Oncol. 1989 Sep;7(9):1252-9. Review.

PMID:
2671284
16.

Tumor inductions by cytostatics in man.

Hunstein W.

Recent Results Cancer Res. 1975;(52):50-6. Review. No abstract available.

PMID:
796914
17.

Chemically induced leukemia in humans.

Adamson RH, Seiber SM.

Environ Health Perspect. 1981 Jun;39:93-103. Review.

18.

Male gonadal toxicity.

Meistrich ML.

Pediatr Blood Cancer. 2009 Aug;53(2):261-6. doi: 10.1002/pbc.22004. Review.

19.

Primary radiation therapy and breast cancer.

Harris JR, Levene MB, Hellman S.

Annu Rev Med. 1981;32:387-404. Review. No abstract available.

PMID:
7013676
20.

LEUKEMIA FOLLOWING IRRADIATION.

GUNZ FW, ATKINSON HR.

Radiology. 1964 Jun;82:1067-71. Review. No abstract available.

PMID:
14168912

Supplemental Content

Support Center